ResMed Inc.

ResMed Inc.

RMDNYSEHealthcare
$238.97
down -3.26 (-1.35%)

1-Year Price

-11.77% past year
ResMed Inc. (RMD) 1-year price chart: down 11.77% from $270.85 on Oct 2025 to $238.97 on Oct 2026. Closing range $182.82 to $283.28.

EquityGlimpse Score

Overall
7.3/10
Wide Moat

Strong, durable competitive advantages versus peers.

Growth
5

Valuation, profitability, financial health, dividend and sentiment scores for ResMed Inc. (RMD) are available to EquityGlimpse members.

Market Cap
33.61B
P/E Ratio
18.67
EPS
$10.53
52W High
$277.67
52W Low
$180.27
Volume
2.52M
Beta
0.75
Dividend Yield
1.24%
Fair value estimate: sign up to see
Is RMD over- or undervalued? Run DCF and multiples models on EquityGlimpse.
See fair value

Key Financial Metrics

Price to Sales
4.99
Price to Book
4.28
EV/EBITDA
12.80
Free CF per Share
$11.40
Op. CF per Share
$12.48
Debt to Equity
0.13
Gross Margin
61.06%
Net Margin
26.94%

About ResMed Inc.

ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.

CEO
Michael J. Farrell
Industry
Medical - Instruments & Supplies
Employees
11,370
IPO Date
1995-06-02
Country
US
Website
Unlock Full Analysis

Get the complete picture on ResMed Inc.

Sign up for EquityGlimpse to access deep fundamental data, AI reports, valuation models, and real-time tracking for RMD and 8,500+ other stocks.

30 Years of Financials
Income statements, balance sheets, and cash flows with 70+ interactive charts
AI-Powered Analysis
Generate professional research reports with 15+ AI models
DCF Valuation
Run discounted cash flow models with customizable assumptions
Portfolio Tracking
Track real-time P&L, sector allocation, and dividend projections
Earnings Intelligence
Surprise tracking, revision momentum, and whisper estimates
Insider & Congress Trades
Monitor what insiders and Congress members are buying and selling

Starting at $8.25/month. 7-day free trial. Cancel anytime.